The effectiveness and safety associated with resumption of oral anticoagulation in atrial fibrillation patients who survive an intracranial hemorrhage
Latest Information Update: 12 Dec 2019
At a glance
- Drugs Apixaban (Primary) ; Dabigatran etexilate (Primary) ; Edoxaban (Primary) ; Rivaroxaban (Primary) ; Warfarin (Primary)
- Indications Cerebral haemorrhage; Intracranial haemorrhages; Ischaemic stroke; Subarachnoid haemorrhage; Thromboembolism
- Focus Therapeutic Use
Most Recent Events
- 12 Dec 2019 New trial record
- 06 Dec 2019 Results published in the American Journal of Cardiovascular Drugs